Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Stacchiotti

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'P Schöffski, A Wozniak, B Kasper, et al.
Acta Oncologica (Stockholm, Sweden)|September 29, 2020
Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?R L Haas, I Walraven, E Lecointe-Artzner, et al.
ESMO Open|March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trialA Vanzulli, R Vigorito, C Buonomenna, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus GroupS Stacchiotti, A Gronchi, P Fossati, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 14, 2020
The sacral chordoma marginS Radaelli, P Fossati, S Stacchiotti, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'P Schöffski, A Wozniak, B Kasper, et al.
Acta Oncologica (Stockholm, Sweden)|September 29, 2020
Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?R L Haas, I Walraven, E Lecointe-Artzner, et al.
ESMO Open|March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trialA Vanzulli, R Vigorito, C Buonomenna, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus GroupS Stacchiotti, A Gronchi, P Fossati, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 14, 2020
The sacral chordoma marginS Radaelli, P Fossati, S Stacchiotti, et al.
Pageof 7